Abstract

Background: Chronic venous insufficiency (CVI) is a frequent pathology that affects quality of life of the patients due to several symptoms such as pain, leg cramps, aching and itch. Our scope was to verify the usefulness of a supplement based on α-lipoc acid, Leucoselect® and Ginkgoselect® phytosome in patients with CVI. Methods: From July to November 2015, 30 consecutive patients with CVI received once a day a tablet containing the supplement for a period of 4 weeks. A control group of 30 subjects taking placebo and matched for CVI class, age and sex was also recruited. Clinical evaluation using VCSS and microcirculatory assessment with perimalleolar capillaroscopy were performed. A questionnaire consisting of two questions investigating presence of pain and itch/ paraesthesia was also given to the patients. Each question was scored on a dichotomous Likert scale (0=no; 1=yes). Results: A significant reduction of VCSS from baseline to 4-weeks was observed in the group of treatment respect to control group (2.70 ± 0.95 vs 0.93 ± 0.74 and 2.87 ± 0.86 vs 2.60 ± 0.81, p<0.0001). Itch and paresthesias resolved in 86.7% of patients vs 26.7% of control (p<0.0001) while leg pain improved in 70% of cases vs 23.3% of control (p<0.001). No significant changes were found between baseline and 4-weeks capillaroscopic pattern in both groups. Conclusions: After 4-weeks of treatment with α-lipoc acid, leucoselect and ginkgoselect phytosoma we observed clinical improvement of CVI symptoms, especially itch and paresthesias.

Highlights

  • Chronic venous insufficiency (CVI) is a common pathology affecting mainly lower limbs [1]

  • We selected a control group of consecutive subject with CVI symptoms matched for CVI class, age and sex recruited from April to May 2016 that received placebo administered in a single-blind manner for the period of the study

  • After 4 weeks of treatment there has been a significant clinical improvement of CVI symptoms in patients treated with supplement as evaluated with VCSS

Read more

Summary

Introduction

Chronic venous insufficiency (CVI) is a common pathology affecting mainly lower limbs [1]. Symptoms usually reported by patients are pain, leg cramps, aching and itch. Itch has been shown to significantly influencing the quality of life of CVI patients [2]. The aim of our work was to verify the usefulness of α-lipoc acid, Leucoselect® and Ginkgoselect® phytosome in patients with CVI. Leucoselect® Phytosome® is a formulation of lower procyanidin oligomers from grape seed and soy lecithin to further improve their absorption. Chronic venous insufficiency (CVI) is a frequent pathology that affects quality of life of the patients due to several symptoms such as pain, leg cramps, aching and itch. Our scope was to verify the usefulness of a supplement based on α-lipoc acid, Leucoselect® and Ginkgoselect® phytosome in patients with CVI

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.